| Sequence 1: | NP_003374.3 | Gene: | VLDLR / 7436 | HGNCID: | 12698 | Length: | 873 | Species: | Homo sapiens |
|---|---|---|---|---|---|---|---|---|---|
| Sequence 2: | NP_037287.2 | Gene: | Vldlr / 25696 | RGDID: | 3963 | Length: | 873 | Species: | Rattus norvegicus |
| Alignment Length: | 873 | Identity: | 838/873 - (95%) |
|---|---|---|---|
| Similarity: | 857/873 - (98%) | Gaps: | 0/873 - (0%) |
- Green bases have known domain annotations that are detailed below.
|
Human 1 MGTSALWALWLLLALCWAPRESGATGTGRKAKCEPSQFQCTNGRCITLLWKCDGDEDCVDGSDEK 65
Human 66 NCVKKTCAESDFVCNNGQCVPSRWKCDGDPDCEDGSDESPEQCHMRTCRIHEISCGAHSTQCIPV 130
Human 131 SWRCDGENDCDSGEDEENCGNITCSPDEFTCSSGRCISRNFVCNGQDDCSDGSDELDCAPPTCGA 195
Human 196 HEFQCSTSSCIPISWVCDDDADCSDQSDESLEQCGRQPVIHTKCPASEIQCGSGECIHKKWRCDG 260
Human 261 DPDCKDGSDEVNCPSRTCRPDQFECEDGSCIHGSRQCNGIRDCVDGSDEVNCKNVNQCLGPGKFK 325
Human 326 CRSGECIDISKVCNQEQDCRDWSDEPLKECHINECLVNNGGCSHICKDLVIGYECDCAAGFELID 390
Human 391 RKTCGDIDECQNPGICSQICINLKGGYKCECSRGYQMDLATGVCKAVGKEPSLIFTNRRDIRKIG 455
Human 456 LERKEYIQLVEQLRNTVALDADIAAQKLFWADLSQKAIFSASIDDKVGRHVKMIDNVYNPAAIAV 520
Human 521 DWVYKTIYWTDAASKTISVATLDGTKRKFLFNSDLREPASIAVDPLSGFVYWSDWGEPAKIEKAG 585
Human 586 MNGFDRRPLVTADIQWPNGITLDLIKSRLYWLDSKLHMLSSVDLNGQDRRIVLKSLEFLAHPLAL 650
Human 651 TIFEDRVYWIDGENEAVYGANKFTGSELATLVNNLNDAQDIIVYHELVQPSGKNWCEEDMENGGC 715
Human 716 EYLCLPAPQINDHSPKYTCSCPSGYNVEENGRDCQSTATTVTYSETKDTNTTEISATSGLVPGGI 780
Human 781 NVTTAVSEVSVPPKGTSAAWAILPLLLLVMAAVGGYLMWRNWQHKNMKSMNFDNPVYLKTTEEDL 845
Human 846 SIDIGRHSASVGHTYPAISVVSTDDDLA 873 |
| Gene | Sequence | Domain | Region | External ID | Identity |
|---|---|---|---|---|---|
| VLDLR | NP_003374.3 | LDLa | 33..67 | CDD:238060 | 30/33 (91%) |
| LDLa | 71..103 | CDD:197566 | 28/31 (90%) | ||
| Ldl_recept_a | 111..149 | CDD:395011 | 33/37 (89%) | ||
| LDLa | 154..188 | CDD:238060 | 30/33 (91%) | ||
| Ldl_recept_a | 192..224 | CDD:395011 | 30/31 (97%) | ||
| Ldl_recept_a | 237..273 | CDD:395011 | 34/35 (97%) | ||
| Ldl_recept_a | 276..312 | CDD:395011 | 35/35 (100%) | ||
| Ldl_recept_a | 320..350 | CDD:395011 | 27/29 (93%) | ||
| FXa_inhibition | 360..394 | CDD:464251 | 33/33 (100%) | ||
| EGF_CA | 396..426 | CDD:214542 | 29/29 (100%) | ||
| Ldl_recept_b | 481..522 | CDD:459654 | 39/40 (98%) | ||
| LY | 505..547 | CDD:214531 | 40/41 (98%) | ||
| Ldl_recept_b | 568..608 | CDD:459654 | 38/39 (97%) | ||
| LY | 592..634 | CDD:214531 | 39/41 (95%) | ||
| Ldl_recept_b | 655..695 | CDD:459654 | 38/39 (97%) | ||
| FXa_inhibition | 706..749 | CDD:464251 | 40/42 (95%) | ||
| Vldlr | NP_037287.2 | LDLa | 33..67 | CDD:238060 | 30/33 (91%) |
| LDLa | 71..103 | CDD:197566 | 28/31 (90%) | ||
| Ldl_recept_a | 111..149 | CDD:395011 | 33/37 (89%) | ||
| Ldl_recept_a | 153..188 | CDD:395011 | 31/34 (91%) | ||
| LDLa | 192..224 | CDD:197566 | 30/31 (97%) | ||
| Ldl_recept_a | 237..273 | CDD:395011 | 34/35 (97%) | ||
| Ldl_recept_a | 276..312 | CDD:395011 | 35/35 (100%) | ||
| Ldl_recept_a | 320..350 | CDD:395011 | 27/29 (93%) | ||
| FXa_inhibition | 360..394 | CDD:464251 | 33/33 (100%) | ||
| EGF_CA | 396..426 | CDD:214542 | 29/29 (100%) | ||
| LDL-receptor class B 1 | 439..480 | 40/40 (100%) | |||
| LY | 461..499 | CDD:214531 | 37/37 (100%) | ||
| LDL-receptor class B 2 | 481..524 | 41/42 (98%) | |||
| Ldl_recept_b | 481..522 | CDD:459654 | 39/40 (98%) | ||
| LDL-receptor class B 3 | 525..567 | 41/41 (100%) | |||
| Ldl_recept_b | 527..565 | CDD:459654 | 37/37 (100%) | ||
| LDL-receptor class B 4 | 568..611 | 41/42 (98%) | |||
| Ldl_recept_b | 568..608 | CDD:459654 | 38/39 (97%) | ||
| LY | 592..634 | CDD:214531 | 39/41 (95%) | ||
| LDL-receptor class B 5 | 612..654 | 41/41 (100%) | |||
| LDL-receptor class B 6 | 655..697 | 40/41 (98%) | |||
| Ldl_recept_b | 655..695 | CDD:459654 | 38/39 (97%) | ||
| FXa_inhibition | 706..749 | CDD:464251 | 40/42 (95%) | ||
| Clustered O-linked oligosaccharides | 751..790 | 32/38 (84%) | |||
| Endocytosis signal. /evidence=ECO:0000255 | 832..837 | 4/4 (100%) |